The Global Head and Neck Cancer Market Size is expected to gain traction, due to the factors such as increasing consumption of tobacco, and rising geriatric population across the world.

Cancer is a disease in which the abnormal cells divide uncontrollably which damage other body tissue. Head and neck cancer is a terminology that is defined as malignant tumour around the neck. This cancer starts with squamous cells, that are found in the moist line surfaces in the lining of head and neck. Head and neck cancer is characterized by the symptoms such as; red & white patch in the mouth, lump or bump in the neck area with or without pain, persistent sore throat, difficulty breathing, double vision, jaw pain, loosening of teeth, unexpected weight loss, and fatigue. Majorly, head & neck cancer is majorly treated with chemotherapy, radiation therapy, and targeted therapy. Targeted therapies would hold the major share during the forecast period due to its effective results.

Head and neck cancer is often influenced by excessive intake of tobacco and alcohol, which accounts approximately 85% of population suffering from head and neck cancer. According to America Society of Clinical Oncology, head and neck cancer accounts 3% of all cancer in the U.S. Also in 2017 number of people suffering from head & neck cancer would be 63,030 which is majorly diagnosed over the age of 50 years.

Rising demand for effective treatments and favourable government regulations for promoting the use combination drugs will support the growth of global market.  

Growth in global head and neck cancer market is primarily driven by the rising prevalence of oropharyngeal cancer, and increasing awareness for minimal invasive surgeries for the treatment of head and neck cancer. Furthermore, increased understanding of pathophysiology for analysis of head and neck cancer to boost head and neck cancer market. Additionally, increased government funding for the improvement of healthcare infrastructure in developing countries would support the entire cancer treatment industry in the coming years.

However, high cost of targeted therapy as an effective treatment option, and relatively low awareness for targeted treatments among the developing countries might hinder the growth of global market in the near future.

Global Head and Neck Cancer Market Taxonomy

The global market is segmented on the basis of cancer type, diagnostic techniques, treatment type, end users, and geography.

On the basis of cancer type, the global head and neck cancer market is segmented into:

• Oral or Oropharyngeal Cancer
• Salivary Gland Cancer
• Nasopharyngeal
• Laryngeal or Hypo Pharyngeal Cancer

On the basis of diagnostic technique type, the global head and neck cancer market is segmented into:

• Diagnostic Imaging Equipment
• PET/CT Scan
• MRI
• X-Ray
• Endoscopy Screening
• Pharyngoscopy
• Laryngoscopy
• Biopsy
• Blood Test
• Dental Diagnostic Equipment

On the basis of treatment type, the global head and neck cancer market is segmented into:

• Chemotherapy
• Surgery
• Targeted Therapy
• Radiation Therapy

On the basis of end use type, the global head and neck cancer market is segmented into:

• Surgical Centres
• Cancer Care Clinics

Geographically, the global head & neck cancer market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Increased expenditure on R&D for developing new and effective treatments to lead the growth of head and neck market in North America.

Geographically, the global market is segmented as North America, Europe, Asia Pacific, Latin America & Middle East and Africa. North America is expected to dominate global head & neck cancer market over the forecast period. North America holds major share owing to the continuous technological developments by increasing R&D investments from the major players and government. While, increasing awareness for the use of targeted therapies would also spur head & neck cancer market of North America.

However, Asia Pacific market is estimated to grow rapidly during the forecast period is majorly attributed to increased tobacco addiction in the youths in Asia Pacific. Additionally, increasing healthcare expenditure by the government in these developing countries would also influence market during the forecast period.

Key players in the global head and neck cancer market are:

• Bayer Healthcare AG
• Boston Biomedical, Inc.
• Bristol-Myers Squibb Company
• Astellas Pharma Inc.
• AbbVie Inc.
• AstraZeneca Plc.
• Acceleron Pharma Inc.
• DentalEZ, Inc.
• Koninklijke Philips N.V.
• Siemens Healthcare Private Limited
• AB Sciences
• AdDent Incorporated